Hemostasis Products - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240908

Publication Date:

September 24, 2024

Pages:

144

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Hemostasis听or听haemostasis听is a process which causes听bleeding听to stop, meaning to keep听blood听within a damaged听blood vessel听(the opposite of hemostasis is听hemorrhage). It is the first stage of听wound healing.听
The global market for Hemostasis Products was estimated to be worth US$ 3303.8 million in 2023 and is forecast to a readjusted size of US$ 4856.2 million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030
The Hemostasis Products market is experiencing steady growth due to the rising incidence of surgical procedures and bleeding disorders. Hemostasis products are crucial in controlling bleeding and promoting clotting during surgeries and in patients with coagulation disorders. The market is driven by advancements in hemostatic technologies, such as topical hemostats, sealants, and adhesives, which offer improved efficacy and ease of use. Additionally, an aging population, increased prevalence of chronic diseases, and a growing emphasis on minimally invasive surgeries contribute to market expansion. The demand for hemostasis products in emergency care and trauma cases is also rising. However, stringent regulatory requirements and the presence of alternative hemostatic techniques may pose challenges to market players.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hemostasis Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemostasis Products by region & country, by Type, and by Application.
The Hemostasis Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostasis Products.
麻豆原创 Segmentation
By Company
Johnson & Johnson
Baxter
BD
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Segment by Type:
Absorbable Hemostatic Products
Non-absorbable Hemostatic Products
Segment by Application
Hospitals
Clinics
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hemostasis Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hemostasis Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hemostasis Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Hemostasis Products Product Introduction
1.2 Global Hemostasis Products 麻豆原创 Size Forecast
1.2.1 Global Hemostasis Products Sales Value (2019-2030)
1.2.2 Global Hemostasis Products Sales Volume (2019-2030)
1.2.3 Global Hemostasis Products Sales Price (2019-2030)
1.3 Hemostasis Products 麻豆原创 Trends & Drivers
1.3.1 Hemostasis Products Industry Trends
1.3.2 Hemostasis Products 麻豆原创 Drivers & Opportunity
1.3.3 Hemostasis Products 麻豆原创 Challenges
1.3.4 Hemostasis Products 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemostasis Products Players Revenue Ranking (2023)
2.2 Global Hemostasis Products Revenue by Company (2019-2024)
2.3 Global Hemostasis Products Players Sales Volume Ranking (2023)
2.4 Global Hemostasis Products Sales Volume by Company Players (2019-2024)
2.5 Global Hemostasis Products Average Price by Company (2019-2024)
2.6 Key Manufacturers Hemostasis Products Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Hemostasis Products Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hemostasis Products
2.9 Hemostasis Products 麻豆原创 Competitive Analysis
2.9.1 Hemostasis Products 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Hemostasis Products Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostasis Products as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Absorbable Hemostatic Products
3.1.2 Non-absorbable Hemostatic Products
3.2 Global Hemostasis Products Sales Value by Type
3.2.1 Global Hemostasis Products Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hemostasis Products Sales Value, by Type (2019-2030)
3.2.3 Global Hemostasis Products Sales Value, by Type (%) (2019-2030)
3.3 Global Hemostasis Products Sales Volume by Type
3.3.1 Global Hemostasis Products Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Hemostasis Products Sales Volume, by Type (2019-2030)
3.3.3 Global Hemostasis Products Sales Volume, by Type (%) (2019-2030)
3.4 Global Hemostasis Products Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Hemostasis Products Sales Value by Application
4.2.1 Global Hemostasis Products Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hemostasis Products Sales Value, by Application (2019-2030)
4.2.3 Global Hemostasis Products Sales Value, by Application (%) (2019-2030)
4.3 Global Hemostasis Products Sales Volume by Application
4.3.1 Global Hemostasis Products Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Hemostasis Products Sales Volume, by Application (2019-2030)
4.3.3 Global Hemostasis Products Sales Volume, by Application (%) (2019-2030)
4.4 Global Hemostasis Products Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Hemostasis Products Sales Value by Region
5.1.1 Global Hemostasis Products Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hemostasis Products Sales Value by Region (2019-2024)
5.1.3 Global Hemostasis Products Sales Value by Region (2025-2030)
5.1.4 Global Hemostasis Products Sales Value by Region (%), (2019-2030)
5.2 Global Hemostasis Products Sales Volume by Region
5.2.1 Global Hemostasis Products Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Hemostasis Products Sales Volume by Region (2019-2024)
5.2.3 Global Hemostasis Products Sales Volume by Region (2025-2030)
5.2.4 Global Hemostasis Products Sales Volume by Region (%), (2019-2030)
5.3 Global Hemostasis Products Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Hemostasis Products Sales Value, 2019-2030
5.4.2 North America Hemostasis Products Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Hemostasis Products Sales Value, 2019-2030
5.5.2 Europe Hemostasis Products Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Hemostasis Products Sales Value, 2019-2030
5.6.2 Asia Pacific Hemostasis Products Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Hemostasis Products Sales Value, 2019-2030
5.7.2 South America Hemostasis Products Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hemostasis Products Sales Value, 2019-2030
5.8.2 Middle East & Africa Hemostasis Products Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemostasis Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hemostasis Products Sales Value
6.2.1 Key Countries/Regions Hemostasis Products Sales Value, 2019-2030
6.2.2 Key Countries/Regions Hemostasis Products Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Hemostasis Products Sales Value, 2019-2030
6.3.2 United States Hemostasis Products Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hemostasis Products Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hemostasis Products Sales Value, 2019-2030
6.4.2 Europe Hemostasis Products Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hemostasis Products Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hemostasis Products Sales Value, 2019-2030
6.5.2 China Hemostasis Products Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hemostasis Products Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hemostasis Products Sales Value, 2019-2030
6.6.2 Japan Hemostasis Products Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hemostasis Products Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hemostasis Products Sales Value, 2019-2030
6.7.2 South Korea Hemostasis Products Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hemostasis Products Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hemostasis Products Sales Value, 2019-2030
6.8.2 Southeast Asia Hemostasis Products Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hemostasis Products Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hemostasis Products Sales Value, 2019-2030
6.9.2 India Hemostasis Products Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hemostasis Products Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Information
7.1.2 Johnson & Johnson Introduction and Business Overview
7.1.3 Johnson & Johnson Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Johnson & Johnson Hemostasis Products Product Offerings
7.1.5 Johnson & Johnson Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter Hemostasis Products Product Offerings
7.2.5 Baxter Recent Development
7.3 BD
7.3.1 BD Company Information
7.3.2 BD Introduction and Business Overview
7.3.3 BD Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BD Hemostasis Products Product Offerings
7.3.5 BD Recent Development
7.4 B Braun
7.4.1 B Braun Company Information
7.4.2 B Braun Introduction and Business Overview
7.4.3 B Braun Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.4.4 B Braun Hemostasis Products Product Offerings
7.4.5 B Braun Recent Development
7.5 Gelita
7.5.1 Gelita Company Information
7.5.2 Gelita Introduction and Business Overview
7.5.3 Gelita Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Gelita Hemostasis Products Product Offerings
7.5.5 Gelita Recent Development
7.6 Integra Life Sciences
7.6.1 Integra Life Sciences Company Information
7.6.2 Integra Life Sciences Introduction and Business Overview
7.6.3 Integra Life Sciences Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Integra Life Sciences Hemostasis Products Product Offerings
7.6.5 Integra Life Sciences Recent Development
7.7 Advance Medical Solution
7.7.1 Advance Medical Solution Company Information
7.7.2 Advance Medical Solution Introduction and Business Overview
7.7.3 Advance Medical Solution Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Advance Medical Solution Hemostasis Products Product Offerings
7.7.5 Advance Medical Solution Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Hemostasis Products Product Offerings
7.8.5 Pfizer Recent Development
7.9 CSL Behring
7.9.1 CSL Behring Company Information
7.9.2 CSL Behring Introduction and Business Overview
7.9.3 CSL Behring Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.9.4 CSL Behring Hemostasis Products Product Offerings
7.9.5 CSL Behring Recent Development
7.10 CryoLife
7.10.1 CryoLife Company Information
7.10.2 CryoLife Introduction and Business Overview
7.10.3 CryoLife Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.10.4 CryoLife Hemostasis Products Product Offerings
7.10.5 CryoLife Recent Development
7.11 Zimmer Biomet
7.11.1 Zimmer Biomet Company Information
7.11.2 Zimmer Biomet Introduction and Business Overview
7.11.3 Zimmer Biomet Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Zimmer Biomet Hemostasis Products Product Offerings
7.11.5 Zimmer Biomet Recent Development
7.12 Ferrosan Medical Devices
7.12.1 Ferrosan Medical Devices Company Information
7.12.2 Ferrosan Medical Devices Introduction and Business Overview
7.12.3 Ferrosan Medical Devices Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Ferrosan Medical Devices Hemostasis Products Product Offerings
7.12.5 Ferrosan Medical Devices Recent Development
7.13 Medtronic
7.13.1 Medtronic Company Information
7.13.2 Medtronic Introduction and Business Overview
7.13.3 Medtronic Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Medtronic Hemostasis Products Product Offerings
7.13.5 Medtronic Recent Development
7.14 Smith & Nephew
7.14.1 Smith & Nephew Company Information
7.14.2 Smith & Nephew Introduction and Business Overview
7.14.3 Smith & Nephew Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Smith & Nephew Hemostasis Products Product Offerings
7.14.5 Smith & Nephew Recent Development
7.15 Z-Medica
7.15.1 Z-Medica Company Information
7.15.2 Z-Medica Introduction and Business Overview
7.15.3 Z-Medica Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Z-Medica Hemostasis Products Product Offerings
7.15.5 Z-Medica Recent Development
7.16 Cohera Medical
7.16.1 Cohera Medical Company Information
7.16.2 Cohera Medical Introduction and Business Overview
7.16.3 Cohera Medical Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Cohera Medical Hemostasis Products Product Offerings
7.16.5 Cohera Medical Recent Development
7.17 Marine Polymer
7.17.1 Marine Polymer Company Information
7.17.2 Marine Polymer Introduction and Business Overview
7.17.3 Marine Polymer Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Marine Polymer Hemostasis Products Product Offerings
7.17.5 Marine Polymer Recent Development
8 Industry Chain Analysis
8.1 Hemostasis Products Industrial Chain
8.2 Hemostasis Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hemostasis Products Sales Model
8.5.2 Sales Channel
8.5.3 Hemostasis Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Johnson & Johnson
Baxter
BD
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.